Actively Recruiting

Age: 18Years +
All Genders
NCT07242248

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Led by Janssen-Cilag Ltd. · Updated on 2026-05-08

220

Participants Needed

1

Research Sites

173 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the outcomes of treatment (clinical outcomes) in adult participants with moderately to severely active Ulcerative Colitis (UC) or Crohn's Disease (CD) under real-world settings. CD and UC are the main type of Inflammatory bowel disease, a group of inflammatory conditions of the colon and small intestine.

CONDITIONS

Official Title

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be eligible for biologic treatment and start Guselkumab according to approved guidelines decided by the treating physician
  • Must have a confirmed diagnosis of moderate-to-severe Crohn's Disease or Ulcerative Colitis recorded in medical records
  • Must sign an informed consent form allowing data verification as required locally
Not Eligible

You will not qualify if you...

  • Contraindicated to Guselkumab according to its label
  • Currently enrolled in an interventional clinical study
  • Previously treated with interleukin-23 inhibitors including Guselkumab, Risankizumab, or Mirikizumab, except if previously treated with Ustekinumab
  • History of more than 4 lines of advanced inflammatory bowel disease therapy (biologics or small molecules)
  • Unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

London North West University Healthcare NHS Trust

Harrow, United Kingdom, HA1 3UJ

Actively Recruiting

Loading map...

Research Team

S

Study Contact

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK) | DecenTrialz